In a first-of-a-kind study, Washington State University scientists examined how peoples' self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home. Their work, published this month in the Journal of … [Read more...] about Scientific Guidelines for Using Cannabis to Treat Stress, Anxiety and Depression
In fighting the deadliest form of brain cancer, Glioblastoma, cancer specialists have been extremely frustrated by the inability of anticancer drugs to penetrate the blood-brain barrier (BBB). Now, for the first time, a drug is being developed which has shown in clinical testing … [Read more...] about Breakthrough Cancer Technology, First to Cross Blood-Brain Barrier, Fights Glioblastoma Cells Directly
In a multicenter database study of adults who had undergone surgery for spinal deformities, researchers say that those who had used narcotics daily on average had worse outcomes, such as longer intensive care unit stays and more severe postop disability, compared with those who … [Read more...] about Evidence Mounts That Daily Opioid Users May Fare Worse After Spine Surgery
DDD spoke with Andrew Dahl, CEO of ZIVO, to learn more about the potential of phamacognosy. 1. What is the historical precedent for using pharmacognosy, the search in nature for potentially useful compounds, as a tool for drug discovery? It Is the oldest form of … [Read more...] about Could Algae Inspire New Pharmaceuticals?
NASH, short for nonalcoholic steatohepatitis, is a type of liver disease in which liver fat builds up in people. It affects an estimated 16 million Americans, but many don’t know it until it leads to more serious problems like liver failure … [Read more...] about There could be a $35 billion market to treat NASH, a ‘silent disease’ millions are living with — and the competition’s starting to heat up